Publication list
2022
Girgis, M.,
Fekete, K.,
Homoródi, N.,
Márton, S.,
Fekete, I.,
Horváth, L.:
Use of complementary and alternative medicine among patients with epilepsy and diabetes mellitus, focusing on the outcome of treatment.
Front. Neurosci. 15 1-12, 2022.
Journal metrics:
Q2 Neuroscience (miscellaneous)
2016
Bagoly, Z.,
Homoródi, N.,
Kovács, E.,
Sarkady, F.,
Csiba, L.,
Édes, I.,
Muszbek, L.:
How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.
Journal metrics:
Q2 Hematology
Q2 Medicine (miscellaneous)
Homoródi, N.,
Kovács, E.,
Leé, S.,
Katona, É.,
Shemirani, A.,
Haramura, G.,
Balogh, L.,
Bereczky, Z.,
Szőke, G.,
Péterfy, H.,
Kiss, R.,
Édes, I.,
Muszbek, L.:
The lack of aspirin resistance in patients with coronary artery disease.
J. Transl. Med. 14 (1), 74, 2016.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2014
Kovács, E.,
Katona, É.,
Bereczky, Z.,
Homoródi, N.,
Balogh, L.,
Tóth, E.,
Péterfy, H.,
Kiss, R.,
Édes, I.,
Muszbek, L.:
Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods.
Thromb. Res. 133 (5), 811-816, 2014.
2013
Kovács, E.,
Katona, É.,
Bereczky, Z.,
Homoródi, N.,
Balogh, L.,
Tóth, E.,
Péterfy, H.,
Kiss, R.,
Édes, I.,
Muszbek, L.:
New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
Thromb. Res. 131 (4), 320-324, 2013.
2011
Domokos, É.,
Kardos, L.,
Bednárszky, I.,
Bene, O.,
Bódi, A.,
Daragó, A.,
Fülöp, T.,
Homoródi, N.,
Péter, A.,
Rácz, I.,
Hegedűs, I.,
Kertész, A.:
Az interventrikuláris szeptum mérése echokardiográfiával: mérési különbségek és klinikai következményeik.
Cardiol. Hung. 41 15-20, 2011.
2007
Szűk, T.,
Gyöngyösi, M.,
Homoródi, N.,
Kristóf, É.,
Király, C.,
Édes, I.,
Facskó, A.,
Pavo, N.,
Sodeck, G.,
Strehblow, C.,
Farhan, S.,
Maurer, G.,
Glogar, D.,
Domanovits, H.,
Huber, K.,
Édes, I.:
Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
Am. Heart. J. 153 (2), 289-295, 2007.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
2005
Kőszegi, Z.,
Homoródi, N.,
Bódi, A.,
Vaszily, M.,
Vajda, G.,
Kollár, J.,
Édes, I.:
Giant Pulmonary Aneurysm Associated With Pulmonary Valve Agenesia.
Circulation. 112 (15), e263-e264, 2005.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Physiology (medical)
updated: 2024-04-21, 01:44
